Skip to main content
PMC home page
British Medical Journal logoLink to British Medical Journal
. 1954 Nov 20;2(4898):1181–1193. doi: 10.1136/bmj.2.4898.1181

The Treatment of Severe Hypertension*

M L Rosenheim
PMCID: PMC2080143  PMID: 13209078

Full text

PDF
1181

Images in this article

1181Fig. 1
on p.1181
1182Fig. 2
on p.1182
1184-2Fig. D
on p.1184-2
1184-2Fig. E
on p.1184-2
1184-2Fig. F
on p.1184-2
1184-1Fig. A
on p.1184-1
1184-1Fig. B
on p.1184-1
1184-1Fig. C
on p.1184-1

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BANNON W. G., ALLEN E. V. The effect of adrenolytic drugs on pheochromocytoma with functioning metastatic lesions: report of case. Proc Staff Meet Mayo Clin. 1952 Nov 5;27(23):459–464. [PubMed] [Google Scholar]
  2. BURN G. P. Urinary excretion of the pressor amines in relation to phaeochromocytoma. Br Med J. 1953 Mar 28;1(4812):697–699. doi: 10.1136/bmj.1.4812.697. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Butler A. M. CHRONIC PYELONEPHRITIS AND ARTERIAL HYPERTENSION. J Clin Invest. 1937 Nov;16(6):889–897. doi: 10.1172/JCI100915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. CAHILL G. F. Pheochromocytoma. Bull N Y Acad Med. 1953 Oct;29(10):749–764. [PMC free article] [PubMed] [Google Scholar]
  5. CAMPBELL A. J., GRAHAM J. G., MAXWELL R. D. Treatment of hypertension by oral methonium compounds. Br Med J. 1952 Feb 2;1(4752):251–254. doi: 10.1136/bmj.1.4752.251. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. CAMPBELL A., ROBERTSON E. Treatment of severe hypertension with hexamethonium bromide. Br Med J. 1950 Oct 7;2(4683):804–806. doi: 10.1136/bmj.2.4683.804. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. CHASIS H., GOLDRING W. Salt and protein restriction; effects on blood pressure and renal hemodynamics in hypertensive patients. J Am Med Assoc. 1950 Mar 11;142(10):711–715. doi: 10.1001/jama.1950.02910280019004. [DOI] [PubMed] [Google Scholar]
  8. CURRENS J. H., MYERS G. S., WHITE P. D. The use of protoveratrine in the treatment of hypertensive vascular disease. Am Heart J. 1953 Oct;46(4):576–592. doi: 10.1016/0002-8703(53)90068-4. [DOI] [PubMed] [Google Scholar]
  9. D'ABREU F. Surgery in severe hypertension; a survey of results. Lancet. 1953 Jun 13;1(6772):1164–1169. doi: 10.1016/s0140-6736(53)92461-1. [DOI] [PubMed] [Google Scholar]
  10. DUNCAN G. G., GILL R. J. The management of essential hypertension. N Engl J Med. 1953 Jul 16;249(3):85–90. doi: 10.1056/NEJM195307162490301. [DOI] [PubMed] [Google Scholar]
  11. Decourcy J. L. Subtotal Bilateral Adrenalectomy for Hyperadrenalism (Essential Hypertension). Ann Surg. 1934 Aug;100(2):310–318. doi: 10.1097/00000658-193408000-00006. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. ENGEL A., von EULER U. S. Diagnostic value of increased urinary output of pheochromocytoma. Lancet. 1950 Sep 23;2(6630):387–387. doi: 10.1016/s0140-6736(50)91342-0. [DOI] [PubMed] [Google Scholar]
  13. ENTWISLE G., STONE C. A., LOEW E. R. Pharmacologic basis of various tests used in the diagnosis of pheochromocytoma. Am J Med. 1951 Oct;11(4):461–467. doi: 10.1016/0002-9343(51)90181-7. [DOI] [PubMed] [Google Scholar]
  14. EVANS J. A., RUBITSKY H. J., BARTELS C. C., BARTELS E. C. Re-evaluation of the reliability of pharmacologic and cold pressor studies in hypertension and pheochromocytoma. Am J Med. 1951 Oct;11(4):448–467. doi: 10.1016/0002-9343(51)90180-5. [DOI] [PubMed] [Google Scholar]
  15. FRITZ I., LEVINE R. Action of adrenal cortical steroids and nor-epinephrine on vascular responses of stress in adrenalectomized rats. Am J Physiol. 1951 May;165(2):456–465. doi: 10.1152/ajplegacy.1951.165.2.456. [DOI] [PubMed] [Google Scholar]
  16. GIFFORD R. W., Jr, ROTH G. M., KVALE W. F. Evaluation of new adrenolytic drug (regitine) as test for pheochromocytoma. J Am Med Assoc. 1952 Aug 30;149(18):1628–1634. doi: 10.1001/jama.1952.02930350016005. [DOI] [PubMed] [Google Scholar]
  17. GILL R. J., DUNCAN G. G. Arterial hypertension, the therapeutic effect of cation-exchange resins. N Engl J Med. 1952 Aug 21;247(8):271–276. doi: 10.1056/NEJM195208212470801. [DOI] [PubMed] [Google Scholar]
  18. GOLDENBERG M., ARANOW H., Jr, SMITH A. A., FABER M. Pheochromocytoma and essential hypertensive vascular disease. AMA Arch Intern Med. 1950 Dec;86(6):823–836. doi: 10.1001/archinte.1950.00230180028003. [DOI] [PubMed] [Google Scholar]
  19. GOLDENBERG M. Adrenal medullary function. Am J Med. 1951 May;10(5):627–641. doi: 10.1016/0002-9343(51)90332-4. [DOI] [PubMed] [Google Scholar]
  20. GOLDENBERG M., SERLIN I., EDWARDS T., RAPPORT M. M. Chemical screening methods for the diagnosis of pheochromocytoma. I. Nor-epinephrine and epinephrine in human urine. Am J Med. 1954 Mar;16(3):310–327. doi: 10.1016/0002-9343(54)90349-6. [DOI] [PubMed] [Google Scholar]
  21. GRAHAM J. B. Pheochromocytoma and hypertension; an analysis of 207 cases. Int Abstr Surg. 1951 Feb;92(2):105–121. [PubMed] [Google Scholar]
  22. GREEN D. M., NELSON J. N., DODDS G. A., SMALLEY R. E. Bilateral adrenalectomy in malignant hypertension and diabetes. J Am Med Assoc. 1950 Oct 7;144(6):439–443. doi: 10.1001/jama.1950.02920060001001. [DOI] [PubMed] [Google Scholar]
  23. HARINGTON M. The absorption and excretion of hexamethonium salts. Clin Sci. 1953 May;12(2):185–198. [PubMed] [Google Scholar]
  24. HARRIS E., TURNER R. 1-Hydrazinophthalazine (apresoline) in hypertension. Lancet. 1954 Feb 27;266(6809):429–433. doi: 10.1016/s0140-6736(54)91138-1. [DOI] [PubMed] [Google Scholar]
  25. HARRISON J. H., THORN G. W., CRISCITIELLO M. G. A study of bilateral total adrenalectomy in malignant hypertension and chronic nephritis; preliminary report. J Urol. 1952 Apr;67(4):405–413. doi: 10.1016/S0022-5347(17)68366-6. [DOI] [PubMed] [Google Scholar]
  26. Holton P. Noradrenaline in tumours of the adrenal medulla. J Physiol. 1949 Jun 15;108(4):525–529. doi: 10.1113/jphysiol.1949.sp004355. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. JEFFERS W. A., ZINTEL H. A., HAFKENSCHIEL J. H., HILLS A. G., SELLERS A. M., WOLFERTH C. C. Evaluation of adrenal resection and sympathectomy in ninety-nine persons with hypertension. J Am Med Assoc. 1953 Dec 26;153(17):1502–1505. doi: 10.1001/jama.1953.02940340004002. [DOI] [PubMed] [Google Scholar]
  28. Judson W. E., Epstein F. H., Wilkins R. W. THE COMPARATIVE EFFECTS OF SMALL INTRAVENOUS DOSES OF L-NOR-EPINEPHRINE UPON ARTERIAL PRESSURE AND PULSE RATE IN NOR-MOTENSIVE SUBJECTS AND IN HYPERTENSIVE PATIENTS BEFORE AND AFTER THORACOLUMBAR SYMPATHECTOMY. J Clin Invest. 1950 Oct;29(10):1414–1420. doi: 10.1172/JCI102379. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. KEITH N. M., WAGENER H. P. Recession of neuroretinopathy during the course of malignant hypertension; its occurrence in 15 patients who did not receive directed therapy. AMA Arch Intern Med. 1951 Jan;87(1):25–47. doi: 10.1001/archinte.1951.03810010035004. [DOI] [PubMed] [Google Scholar]
  30. LOCKET S., SWANN P. G., GRIEVE W. S. M. Methonium compounds in the treatment of hypertension. Br Med J. 1951 Apr 14;1(4710):778–784. doi: 10.1136/bmj.1.4710.778. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. MACKEY W. A., SHAW G. B. Oral hexamethonium bromide in essential hypertension. Br Med J. 1951 Aug 4;2(4726):259–265. doi: 10.1136/bmj.2.4726.259. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. MERRILL J. P. The rôle of the adrenal in hypertension. Ann Intern Med. 1952 Nov;37(5):966–971. doi: 10.7326/0003-4819-37-5-966. [DOI] [PubMed] [Google Scholar]
  33. MILNE G. E., OLEESKY S. Excretion of the methonium compounds. Lancet. 1951 Apr 21;1(6660):889–889. doi: 10.1016/s0140-6736(51)91271-8. [DOI] [PubMed] [Google Scholar]
  34. MORRISON B. Parenteral hexamethonium in hypertension. Br Med J. 1953 Jun 13;1(4823):1291–1299. doi: 10.1136/bmj.1.4823.1291. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. MORROW J. D., SCHROEDER H. A., PERRY H. M., Jr Studies on the control of hypertension by hyphex. II. Toxic reactions and side effects. Circulation. 1953 Dec;8(6):829–839. doi: 10.1161/01.cir.8.6.829. [DOI] [PubMed] [Google Scholar]
  36. MOYER J. H., MILLER S. I., FORD R. V. Orally administered hexamethonium chloride in hypertension. J Am Med Assoc. 1953 Jul 18;152(12):1121–1129. doi: 10.1001/jama.1953.03690120037010. [DOI] [PubMed] [Google Scholar]
  37. MURPHY R. J. F. The effect of "rice diet" on plasma volume and extracellular fluid space in hypertensive subjects. J Clin Invest. 1950 Jul;29(7):912–917. doi: 10.1172/JCI102325. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Oliver G., Schäfer E. A. The Physiological Effects of Extracts of the Suprarenal Capsules. J Physiol. 1895 Jul 18;18(3):230–276. doi: 10.1113/jphysiol.1895.sp000564. [DOI] [PMC free article] [PubMed] [Google Scholar]
  39. PERERA G. A., HAELIG A. W. Clinical characteristics of hypertension associated with unilateral renal disease. Circulation. 1952 Oct;6(4):549–552. doi: 10.1161/01.cir.6.4.549. [DOI] [PubMed] [Google Scholar]
  40. PICKERING G. W., HEPTINSTALL R. H. Nephrectomy and other treatment for hypertension in pyelonephritis. Q J Med. 1953 Jan;22(85):1–22. [PubMed] [Google Scholar]
  41. Peart W. S. The nature of splenic sympathin. J Physiol. 1949 Jun 15;108(4):491–501. doi: 10.1113/jphysiol.1949.sp004352. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. RAAB W., HUMPHREYS R. J., LEPESCHKIN E. Potentiation of pressor effects of nor-epinephrine and epinephrine in man by desoxycorticosterone acetate. J Clin Invest. 1950 Oct;29(10):1397–1404. doi: 10.1172/JCI102377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. SCHOTTSTAEDT M. F., SOKOLOW M. The natural history and course of hypertension with papilledema (malignant hypertension). Am Heart J. 1953 Mar;45(3):331–362. doi: 10.1016/0002-8703(53)90147-1. [DOI] [PubMed] [Google Scholar]
  44. SMIRK F. H., ALSTAD K. S. Treatment of arterial hypertension by penta- and hexamethonium salts; based on 150 tests on hypertensives of varied aetiology and 53 patients treated for periods of two to fourteen months. Br Med J. 1951 Jun 2;1(4717):1217–1228. doi: 10.1136/bmj.1.4717.1217. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. SMIRK F. H. Prolongation of action of hypotensive drugs; use of polyvinylpyrrolidone and dextrans to lengthen effects of hexamethonium and hexamethylene bis-ethyldimethyl-ammonium. Lancet. 1952 Oct 11;2(6737):695–699. doi: 10.1016/s0140-6736(52)91317-2. [DOI] [PubMed] [Google Scholar]
  46. SMITHWICK R. H. Continued hypertension; prognosis for surgically treated patients. Br Med J. 1948 Jul 31;2(4569):237–243. doi: 10.1136/bmj.2.4569.237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. SOKOLOW M., SCHOTTSTAEDT M. F. The management of malignant hypertension. Ann Intern Med. 1953 Apr;38(4):647–666. doi: 10.7326/0003-4819-38-4-647. [DOI] [PubMed] [Google Scholar]
  48. THORN G. W., HARRISON J. H., CRISCITIELLO M. G., FRAWLEY T. F. Physiological changes following bilateral total adrenalectomy in patients with advanced hypertensive vascular disease. Trans Assoc Am Physicians. 1951;64:126–136. [PubMed] [Google Scholar]
  49. THORN G. W., HARRISON J. H., MERRILL J. P., CRISCITIELLO M. G., FRAWLEY T. F., FINKENSTAEDT J. T. Clinical studies on bilateral complete adrenalectomy in patients with severe hypertensive vascular disease. Ann Intern Med. 1952 Nov;37(5):972–1005. doi: 10.7326/0003-4819-37-5-972. [DOI] [PubMed] [Google Scholar]
  50. WATKIN D. M., FROEB H. G., HATCH F. T., GUTMAN A. B. Effects of diet in essential hypertension. II. Results with unmodified Kempner rice diet in 50 hospitalized patients. Am J Med. 1950 Oct;9(4):441–493. doi: 10.1016/0002-9343(50)90200-2. [DOI] [PubMed] [Google Scholar]
  51. WEIL-MALHERBE H., BONE A. D. The chemical estimation of adrenaline-like substances in blood. Biochem J. 1952 Jun;51(3):311–318. doi: 10.1042/bj0510311. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. WESTON R. E., HELLMAN L., ESCHER D. J. W., EDELMAN I. S., GROSSMAN J., LEITER L. Studies on the influence of the low sodium cardiac diet and the Kempner regimen on renal hemodynamics and electrolyte excretion in hypertensive subjects. J Clin Invest. 1950 Jun;29(6):639–650. doi: 10.1172/JCI102301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. WHITE P. D., DIMOND E. G., WILLIAMS A. Follow-up study of one hundred private hypertensive patients with cardiovascular complications. J Am Med Assoc. 1950 Aug 12;143(15):1311–1317. doi: 10.1001/jama.1950.02910500013004. [DOI] [PubMed] [Google Scholar]
  54. WOLFERTH C. C., JEFFERS W. A., LUKENS F. D. W., ZINTEL H. A., HAFKENSCHIEL J. H. Observations on the results of subtotal adrenalectomy in the treatment of severe, otherwise intractable hypertension and their bearing on the mechanism by which hypertension is maintained. Ann Intern Med. 1951 Jul;35(1):8–18. doi: 10.7326/0003-4819-35-1-8. [DOI] [PubMed] [Google Scholar]
  55. WOLFERTH C. C., JEFFERS W. A., ZINTEL H. A., HAFKENSCHIEL J. H., HILLS A. G. Effects of subtotal adrenalectomy alone and combined with sympathectomy upon the blood pressure levels and complications of severe arterial hypertension. Bull N Y Acad Med. 1953 Feb;29(2):115–137. [PMC free article] [PubMed] [Google Scholar]
  56. Wagener H. P. The Retinitis of Malignant Hypertension. Trans Am Ophthalmol Soc. 1927;25:349–380. [PMC free article] [PubMed] [Google Scholar]

Articles from British Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES